We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Directa Plus Plc | LSE:DCTA | London | Ordinary Share | GB00BSM98843 | ORD 0.25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.20 | -1.04% | 19.00 | 18.00 | 20.00 | 19.00 | 19.00 | 19.00 | 25,143 | 08:00:26 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Carbon And Graphite Products | 11.28M | -4.82M | -0.0730 | -2.60 | 12.55M |
From May 2019 to May 2024
TIDMDCTA
RNS Number : 7618M
Directa Plus PLC
18 October 2016
18 October 2016
Directa Plus plc
("Directa Plus" or the "Company")
Further Two Patents Granted Covering Graphene Plus Production
Directa Plus now has complete protection of entire G+ manufacturing process
Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that Ufficio Brevetti e Marchi (Italian Patent and Trademark Office) has issued notification that a further two patents have been granted covering Directa Plus' proprietary G+ manufacturing process. The Company now has a portfolio of 14 patents granted and eight pending.
Patent MI2014A001123: Process for preparing graphene nanoplatelets (GNPs)
This patent covers the core of Directa Plus' G+ technology, the liquid exfoliation phase, where the Company's material passes from a 3D to 2D state.
Patent MI2014A001124L: Continuous process for preparing pristine GNPs
This patent covers the entire production process of G+ pristine GNPs, which comprises natural graphite expansion, exfoliation and drying to obtain different grades and physical forms of G+ materials.
The patent is focused on the continuous character of the process while maintaining its inherent flexibility for the production of customised graphene-based products. The whole production process does not involve the use of any type of chemistry nor oxidation steps, therefore providing pure materials already certified as non-toxic for human health.
Giulio Cesareo, Chief Executive Officer of Directa Plus, said: "Our intellectual property is a key value driver for the business and so the continued widening of our patent protection is very important to us. It is a major step forward to achieve high volume production at a very low cost. These patents offer us excellent protection as we continue to see the commercial launch of more and more end-user products containing our technology."
Enquiries
Directa Plus plc --------------------------------------- ---------------- Giulio Cesareo, CEO Marco Ferrari, CFO +39 02 36714458 --------------------------------------- ---------------- Cantor Fitzgerald Europe (Nominated Adviser and Broker) --------------------------------------- ---------------- Marc Milmo, David Foreman, Michael Reynolds (Corporate Finance) +44 20 7894 Mark Westcott, David Banks (Sales) 7000 --------------------------------------- ---------------- Luther Pendragon (Financial PR) --------------------------------------- ---------------- Harry Chathli, Claire Norbury, Alexis +44 20 7618 Gore 9100 --------------------------------------- ----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFFIFAWFMSELS
(END) Dow Jones Newswires
October 18, 2016 02:01 ET (06:01 GMT)
1 Year Directa Plus Chart |
1 Month Directa Plus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
